Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-05

Clinical Trial Update: The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness and safety of levosimendan in patients with severe aortic stenosis and heart failure undergoing transcatheter aortic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levosimendan (levosimendan)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Aortic Valve Stenosis, Heart Failure | Phase 4 | Status: UNKNOWN